Anlon Healthcare Share Price Today (AHCL)
TODAY IN ONE LINE
AHCL fell 3.0% on light volume, lagging Nifty's 1.1% move.
With a market cap of ₹784.52 Cr., it trades at a P/E of 30.31. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Anlon Healthcare flags
Key strengths and potential risks.
Green Flags
- ●High Capital EfficiencyROCE of 20.8% indicating pricing power
- ●Strong Return on EquityHealthy ROE of 18.4%
- ●Healthy Operating MarginsOPM is structurally strong at 27.6%
- ●High Promoter HoldingPromoters hold 52.7% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Earnings DeclineEPS (TTM) has contracted by 54.8% YoY
What changed recently?
Recent events, corporate actions, and announcements.
Anlon Healthcare Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Anlon Healthcare Limited, framed against the sector median so the premium or discount is obvious at a glance.
Anlon Healthcare Limited trades at a P/E of 30.31× and P/B of 3.78×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Anlon Healthcare Limited technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Anlon Healthcare Limited — derived from the live tape, not yesterday's close.
Anlon Healthcare Limited last traded at ₹14.73 with an intraday range of ₹14.7–₹15.18 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹14.73| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 16.00 | +1.27 | +8.62% |
| R3 | 15.52 | +0.79 | +5.36% |
| R2 | 15.35 | +0.62 | +4.21% |
| R1 | 15.04 | +0.31 | +2.10% |
| PIVOT | 14.87 | 0.14 | 0.95% |
| CURRENT | 14.73 | — | — |
| S1 | 14.56 | -0.17 | -1.15% |
| S2 | 14.39 | -0.34 | -2.31% |
| S3 | 14.08 | -0.65 | -4.41% |
| S4 | 13.60 | -1.13 | -7.67% |
AHCL is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹14.9–₹15.18
Trading Below opening range, showing Bearishness
Anlon Healthcare Limited financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Anlon Healthcare Limited — consolidated or standalone — with margins, YoY growth and key ratios inline.
Anlon Healthcare Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹784.52 Cr. and reported EPS of ₹0.61.
| Metric | — | Mar 2026 |
|---|---|---|
| Revenue from Operations | — | 172 |
| Other Income | — | 0 |
| Total Income | — | 172 |
| — | 105 | |
| Gross ProfitDerived | — | 67 |
| Gross Margin %Derived | — | 38.88% |
| — | 19 | |
| EBITDA (Operating Profit)Derived | — | 48 |
| OPM %Derived | — | 27.63% |
| — | 5 | |
| Profit Before Tax (PBT) | — | 43 |
| — | 13 | |
| Effective Tax %Derived | — | 31.57% |
| Total Profit for Period | — | 29 |
| Less: Non-controlling Interests | — | 1 |
| Net Profit (Owner's PAT)Derived | — | 29 |
| Net Profit Margin %Derived | — | 16.58% |
| Earnings Per Share (EPS ₹) | — | 0.54 |
| Diluted Shares Outstanding (Cr) | — | 53 |
| Other Comprehensive Income (Net of Tax) | — | -0 |
| Total Expenses (incl. D&A & Interest) | — | 130 |
| Material Cost % of RevenueDerived | — | 86.83% |
| Employee Cost % of RevenueDerived | — | 3.22% |
| Other Cost % of RevenueDerived | — | 8.03% |
| Interest Coverage (x)Derived | — | 12.30x |
| Period | Mar 2026 | Trend |
|---|---|---|
| Revenue from Operations | 172 | |
| Other Income | 0 | |
| Total Income | 172 | |
105 | ||
| Gross ProfitDerived | 67 | |
| Gross Margin %Derived | 38.88% | |
19 | ||
| EBITDA (Operating Profit)Derived | 48 | |
| OPM %Derived | 27.63% | |
5 | ||
| Profit Before Tax (PBT) | 43 | |
13 | ||
| Effective Tax %Derived | 31.57% | |
| Total Profit for Period | 29 | |
| Less: Non-controlling Interests | 1 | |
| Net Profit (Owner's PAT)Derived | 29 | |
| Net Profit Margin %Derived | 16.58% | |
| Earnings Per Share (EPS ₹) | 0.54 | |
| Diluted Shares Outstanding (Cr) | 53 | |
| Other Comprehensive Income (Net of Tax) | -0 | |
| Total Expenses (incl. D&A & Interest) | 130 | |
| Material Cost % of RevenueDerived | 86.83% | |
| Employee Cost % of RevenueDerived | 3.22% | |
| Other Cost % of RevenueDerived | 8.03% | |
| Interest Coverage (x)Derived | 12.30x |
Anlon Healthcare segment analysis : revenue and profit mix.
Disclosed business segments at Anlon Healthcare with their share of revenue and profit, switchable between consolidated and standalone reporting.
Anlon Healthcare discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Anlon Healthcare Limited.
Our AI distills the core fundamental drivers supporting Anlon Healthcare Limited, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
Anlon Healthcare Limited's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Operating margin 26.75% TTM demonstrates strong cost control and pricing power.
Net profit margin 22.18% TTM reflects healthy earnings generation capability.
ROE 18.40% and ROCE 20.80% indicate solid shareholder value creation metrics.
Promoter holding 52.68% signals strong long-term commitment and alignment.
Debt-to-equity ratio 0.0019x substantially mitigates financial leverage risk.
Key Risks.
Latest quarterly EPS declined 36.9% YoY despite revenue growth of 4.01%.
TTM EPS declined 54.8% YoY, highlighting severe earnings volatility and quality concerns.
Negative operating cash flow ₹46.36 Cr signals liquidity stress and earnings quality red flags.
P/E 30.31x TTM trades at premium relative to sector peers; valuation stretched.
Zero dividend yield and zero payout ratio limit income generation for investors.
Flip Conditions.
Valuation risk. a P/E above 39 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 13% would indicate weaker capital compounding.
Anlon Healthcare Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Anlon Healthcare Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Anlon Healthcare Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Anlon Healthcare Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
- 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
- 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
- 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
- 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
- 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Pattern history — every completed pattern and its outcome
Anlon Healthcare Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Anlon Healthcare Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Anlon Healthcare Limited stood at 51.2% of traded volume, against a 20-day average of 46.1%.
Anlon Healthcare announcements: results, concalls, ratings, M&A.
Filings Anlon Healthcare sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Anlon Healthcare files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 95 documents below.
General Updates
Anlon Healthcare Limited has informed the Exchange about General Updates
General Updates
Anlon Healthcare Limited has informed the Exchange about General Updates
General Updates
Disclosure regarding interview/podcast of Chairman & Managing Director with Sumit Mehrotra, former Senior Anchor @cnbcawaaz
Updates
Anlon Healthcare Limited has informed the Exchange regarding interview of Chairman & Managing Director with Money TV'.
Outcome of Board Meeting
Anlon Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on July 01, 2026.
Investor decks & rating reports.
Anlon Healthcare dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Anlon Healthcare has declared, sequenced by announce and record date.
Anlon Healthcare corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Anlon Healthcare Limited: business, sector, key facts.
What Anlon Healthcare Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Anlon Healthcare Limited operates in the Pharmaceuticals industry under the Healthcare sector.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- 3B Blackbio DX (3BBLACKBIO) Share PricePeer
- Abbott India (ABBOTINDIA) Share PricePeer
- Acutaas Chemicals (ACUTAAS) Share PricePeer
- Amanta Healthcare (AMANTA) Share PricePeer
- Ambalal Sarabhai Enterprises (AMBALALSA) Share PricePeer
- Top quality scorecard stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Anlon Healthcare Limited (AHCL).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Anlon Healthcare Limited (AHCL)?
The current share price of Anlon Healthcare Limited (AHCL) is ₹14.73. Today, the stock has declined by ₹0.45 (2.96%), trading in a range of ₹14.7 to ₹15.18. The stock opened at ₹15.15 with a trading volume of 29,92,300 shares.
02Is Anlon Healthcare Limited stock a good investment for long-term?
Anlon Healthcare Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹784.52 crores, P/E ratio of 30.31, ROE of 18.40%, and ROCE of 20.80%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Anlon Healthcare Limited stock?
The 52-week high price of Anlon Healthcare Limited (AHCL) is ₹161, while the 52-week low is ₹12.91. Currently trading at ₹14.73, the stock is 1.2% away from its 52-week low and 90.9% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Anlon Healthcare Limited stock at the current price?
Whether to buy Anlon Healthcare Limited stock at ₹14.73 depends on multiple factors. The stock is currently trading with a P/E ratio of 30.31 and P/B ratio of 3.78. Today's performance shows a loss of 2.96%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Anlon Healthcare Limited and when is the next dividend?
Anlon Healthcare Limited offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹14.73, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Anlon Healthcare Limited?
Anlon Healthcare Limited's key financial metrics include: P/E Ratio: 30.31, P/B Ratio: 3.78, ROE: 18.40%, ROCE: 20.80%, Dividend Yield: 0.00%, EPS: ₹0.61, Book Value: ₹5.11, and Debt-to-Equity: 0.19. The company's market cap stands at ₹784.52 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Anlon Healthcare Limited stock performing today in the market?
Anlon Healthcare Limited stock opened at ₹15.15 and is currently trading at ₹14.73, showing a decline of ₹0.45 (2.96%). The intraday high is ₹15.18 and low is ₹14.7. The trading volume stands at 29,92,300 shares, indicating strong market participation today.
08What is the P/E ratio of Anlon Healthcare Limited and what does it indicate?
Anlon Healthcare Limited has a Price-to-Earnings (P/E) ratio of 30.31, which means investors are willing to pay ₹30.31 for every ₹1 of earnings. With an EPS of ₹0.61, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Anlon Healthcare Limited (AHCL) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.